gabexate has been researched along with Hyperkalemia in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The patient received a continuous infusion of gabexate mesilate at 60 mg x hr(-1) starting about 1 hr after the induction of anesthesia." | 7.76 | [Case of hyperkalemia possibly caused by gabexate mesilate]. ( Doi, T; Goto, T; Kurahashi, K, 2010) |
| " The patient received a continuous infusion of gabexate mesilate at 60 mg x hr(-1) starting about 1 hr after the induction of anesthesia." | 3.76 | [Case of hyperkalemia possibly caused by gabexate mesilate]. ( Doi, T; Goto, T; Kurahashi, K, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, T | 1 |
| Kurahashi, K | 1 |
| Goto, T | 1 |
1 other study available for gabexate and Hyperkalemia
| Article | Year |
|---|---|
[Case of hyperkalemia possibly caused by gabexate mesilate].
Topics: Anesthesia; Female; Gabexate; Humans; Hyperkalemia; Intraoperative Complications; Liver Transplantat | 2010 |